Up to 90 percent of patients undergoing in vitro fertilization (IVF) are opting for costly add-ons, such as acupuncture, steroids, and plasma injections, which do not significantly enhance their chances of conception. Research published in The Lancet Obstetrics, Gynaecology, and Women’s Health reveals that these additional procedures can inflate the already high costs of IVF without yielding meaningful improvements in success rates. The study highlights that many patients, especially after one or two unsuccessful cycles, may feel compelled to try these unproven treatments due to emotional pressure and a desire to avoid future regret. The findings prompt a call for clearer information on the efficacy of such add-ons, emphasizing that many do not have solid evidence supporting their effectiveness. Monash IVF, a major service provider in Australia, acknowledges the lack of proven benefits for certain treatments on its website.
Why It Matters
The reliance on unproven IVF add-ons by a large percentage of patients underscores a significant gap in informed consent and decision-making in reproductive health. Despite the emotional and financial stakes involved in IVF, many patients are led to pursue additional treatments that do not improve success rates, potentially exacerbating their stress and financial burdens. Historical data shows that the IVF process itself is already complex and often emotionally taxing, with many individuals and couples feeling pressured to explore every option available. This situation highlights the urgent need for better regulatory standards and patient education regarding the efficacy of supplementary treatments within reproductive medicine.
Want More Context? 🔎
